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Abstract: Recent evidence has shown that the incidence of long-term illnesses in young people aged
10–24 years is increasing. It is essential to highlight the importance of long-term health conditions in
this age group and understand young people’s health needs to be able to improve current support for
young people. Pharmacists, as medicine experts, are in a unique position to promote young people’s
health. The role of primary care pharmacists in the management of chronic illnesses in young people
has not been widely researched. The aim of this review was to explore the current role of primary care
pharmacists in the management of chronic illnesses in young people aged 10–24 years. A systematic
review was conducted according to the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement using Medical Subject Headings (MeSH) and Embase subject
headings (Emtree) terms, covering three main themes: Pharmacists, young people and chronic
illnesses. Articles were critically appraised using Critical Appraisal Skills Programme (CASP) tools.
Eight articles were included in this review. Seven articles included original research studies (one
observational study, two surveys, two qualitative interview studies and two interventions). The
remaining article was a literature review. All of the articles made reference to community pharmacists,
while there was no information about GP pharmacists. Roles that community pharmacists identified
as high-priority in their practice when dealing with young people included supporting young people
to develop generic healthcare skills, counselling and building trusted relationships directly with
young people, helping young people to find credible health information and the provision of specialist
services. Community pharmacists feel that they have a role to play in supporting young people with
chronic illness and have identified many areas where they can provide services and support.
Keywords: Pharmacist; young people and chronic illnesses
1. Introduction
A UK government survey conducted in 2011 found that approximately 17% of young people aged
10 to 24 years of age have a long-term illness [1]. Common long-term illnesses in this population include
asthma, epilepsy and diabetes, and they require long-term treatment with medication to improve
disease-related morbidity and mortality. Forty-five million prescriptions were dispensed by community
pharmacies for young people in 2017, accounting for approximately 4.1% of all prescriptions and
representing about 7.5% of total National Health Service (NHS) prescription spending [2]. These
figures are the approximate figures of the total number of prescriptions issued to 0–18-year-olds.
A review of medicine use in children from the U.S. National Council on Patient Information and
Education reported that on average, only 54% adhere to their treatment regimen [3]. Lack of adherence
is an issue in patients of all ages, but young people with long-term illnesses face particular challenges.
These challenges can be practical, for example, forgetting to fill a repeat prescription or remembering
to take medicines, but they are often more complex, with multiple factors influencing medicine-taking
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behaviours. The needs and understanding of disease and how to manage it change considerably as young
people progress through teenage years to adulthood, i.e., as they transition from dependence on carers to
self-care. During this transition, young people might find it difficult to make informed and considered
decisions about the benefits of taking medicines versus the side-effects sometimes experienced. This
could be due to a lack of understanding of the diagnosis and effectiveness of therapy [4].
It is not only for reasons of adherence that young people may need additional support from
healthcare professionals. They are also at high risk for medication errors, therapeutic misadventures [5]
and loss to follow-up in the transition from child to adult services [6]. Therapeutic misadventure can
be described as an adverse event or injury caused by medical management rather than underlying
disease [7]. In 2007, there were over 86,000 reported adverse events within the NHS [7]. Evidence
has shown that medication errors in children occur at similar rates to adults but have three times the
potential to cause harm [8].
Recent evidence has shown that the incidence of long-term illnesses in young people aged
10–24 years is increasing [9]. It is essential to highlight the importance of long-term health conditions in
this age group and understand young people’s health needs to be able to improve current support for
young people. Pharmacists working in the community are easily accessible without an appointment.
They are often situated in high streets, neighbourhood centres and supermarkets. For these reasons,
pharmacists are in a unique position to promote child and family health through access to needed
services and psychosocial support [10]. There is an obvious role for pharmacists in ensuring the
safety of medications for young people with long-term conditions through the provision of education
to patients/parents [3]. This role was recognised by the 2004 Department of Health and Social
Care National Service Framework for Children, Young People and Maternity Services. In addition,
community pharmacists could also provide easily accessible continuity of healthcare support during
the transition from children’s to adults’ health services. There is a paucity of current available evidence
regarding the current role of primary care pharmacists in the management of chronic illnesses in
young people aged 10–24 years. The aim of this review was to explore the current role of primary care
pharmacists in the management of chronic illnesses in young people aged 10–24 years.
2. Materials and Methods
2.1. Search Strategy and Data Resources
A systematic review was conducted according to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement by using the four following bibliographic databases:
MEDLINE, EMBASE, Cochrane Library and CINAHL. Articles were identified that explored and
identified the role of primary care pharmacists in the management of young people with chronic illnesses.
Duplicate papers were removed if they were found in different databases. A hand search for relevant
references in the various retrieved studies was also undertaken. The search was mainly based on three
terms, namely, pharmacist, young people and chronic illnesses. Medical Subject Heading (MeSH) terms
and Embase subject headings (Emtree) terms were used in PubMed and Embase, respectively.
2.2. Eligibility Criteria
The scope of the systematic review was limited to research on the role of pharmacists in the
management of chronic illnesses in young people in a primary care setting. Studies delivered in
primary care or community settings and studies in the English language were included. Articles
about the pharmacist’s role in the management of adults (>24 years) and those delivered in a hospital
setting were excluded. Articles were excluded if they discussed healthcare services provided by
nonpharmacists; if they were on acute illness or disability; or if they were from conferences or were
abstracts, letters or case studies.
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2.3. Quality Assessment
The quality of included studies was assessed using Critical Appraisal Skills Programme (CASP)
checklists [11–13]. Due to the methodological heterogeneity of the articles, different types of CASP
checklists were used. The articles were classified into three categories: Qualitative studies, cohort
studies and literature reviews.
3. Results
3.1. Data Extraction
The total number of research results after application of the key words was 1862 citations. These
citations were extracted from the following databases: MEDLINE (n = 690), Cochrane Library (n = 38),
CINAHL Plus (n = 1125), and EMBASE (n = 9). After screening the title and abstracts of these articles,
321 articles were found to be relevant. The abstracts and/or the text of these articles were reviewed, and
24 full-text papers were retrieved either electronically or as paper copies for assessment. Seven articles
were finally identified. A hand search was completed of the reference lists of the relevant seven articles,
and an additional article was added. Therefore, a total of eight articles were considered relevant and
were included in this review. Thirteen articles did not match the inclusion criteria for the following
reasons: Public health (n = 1), not in a community or primary care setting (n = 2), service not provided
by a pharmacist (n = 1), Italian article (n = 1), age not specified (n = 3), immunization or vaccination
(n = 4), and communication (n = 1). Only full texts of articles were included in this review (see Figure 1).
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Figure 1. Article selection chart.
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The eight relevant studies that met the eligibility criteria were conducted in different countries:
The UK (three articles), USA (three), Netherlands (one) and Chile (one).
3.1.1. Study Design
Each of the eight articles included in this review had a different study design. Two studies
were interviews: One was structured face-to-face interviews with community pharmacy staff
members on medication-related problems in adolescents [14], and the other was a qualitative study
using semi-structured interviews and thematic analysis with children and parents to explore their
perspectives regarding paediatric medication use, knowledge, experiences and pharmacist-provided
patient counselling [15]. One study [16] used sequential mixed methods composed of focus groups
with community and hospital pharmacists, telephone interviews with pharmacy and rheumatology
stakeholders and commissioners and multidisciplinary group discussions to prioritize roles generated
by the first two qualitative phases. Benavides et al. [17] conducted a three-month, prospective,
cross-sectional study to utilise clinical pharmacists to identify metabolic syndrome in high-risk
adolescents. Another study [18] was designed as a semi-structured survey of community pharmacists
to explore current practices provided to young people. González-Martin et al., 2003 [19], conducted a
paediatric asthma quality-of-life questionnaire (PAQLQ) to measure the impact of a pharmaceutical
care programme in two groups of children. An observational study was conducted by Carpenter et al.,
2016 [20], to document information about prescriptions that were picked up for children. Finally, one
article [3] was a literature review to identify information on managing medicines in children (see
Table A1).
3.1.2. Participants/Study Groups
Two of the eight studies that met the eligibility criteria were interventions conducted in young
people with specific chronic diseases, asthma [19] and metabolic syndrome [17]. One study was
conducted with young people using medications for chronic conditions and their parents [15], and
one involved families that picked up prescriptions for young people [20]. Three studies [14,16,18]
included community pharmacists exploring the services provided for young people. In Gray et al. [16],
rheumatology physicians, nurses and a physiotherapist were also included. Finally, one paper [3]
reviewed studies that identified information on managing medicine in children (see Table A1).
3.1.3. Overview of Goals of Studies
In three studies [16,17,19], the general aim of the study was to explore and evaluate the
role of pharmacists in the care of young people with chronic illness. The specific objective of
González-Martin et al. [19] was to evaluate the impact of pharmaceutical care on children with
asthma. In Gray et al. [16], the purpose of the study was to explore the perceived and potential
roles of pharmacists in the care of young people with juvenile arthritis. The aim of the work of
Benavides et al. [17] was to evaluate the role of a clinical pharmacist in screening adolescents for
components of metabolic syndrome. Two studies [14,18] aimed to explore community pharmacists’
perspectives regarding medication-related problems in adolescents: Another objective in Reference [18]
was to determine whether community pharmacists undertake medication reviews with children or
their carers. One study aimed to explore the perspectives of children and parents regarding paediatric
patients’ knowledge and medication use experiences for chronic illnesses, how they want to learn
about medicines and perceptions of community pharmacists who provided counselling [15]. The aim
of the observational study [20] was to characterise pharmacists’ interactions with children and their
caregivers. The aim of the final study in this review [3] was to provide underpinning evidence in the
development of advice on managing medicines for children and young people (see Table A1).
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3.1.4. Quality of Studies
The overall assessment of the articles was performed by rating the methodological quality. In five
articles, most of the criteria were fulfilled [3,15–17,19]. In three articles, either not all of the criteria
were fulfilled or they were not adequately described, but it was considered that this would have been
unlikely to alter the conclusions of these articles [14,18,20]. Therefore, for this review, based on the
CASP checklists applied to the eight articles, it is unlikely that different recommendations would have
emerged or that different conclusions would have been found from this review.
3.1.5. Setting
In most studies that met the inclusion criteria, the setting was a community pharmacy [14,15,18,20].
In one study, the intervention was in an outpatient paediatric clinic [19], one study was conducted in
a paediatric ambulatory clinic [14] and in one study [16] the intervention was convened at targeted
paediatric rheumatology centres (see Table A1).
3.2. Details of the Extrapolation
All extrapolations were related to the role of pharmacist in the management of chronic illnesses in
young people, according to the selection criteria. In this section, interventions are described based on
the main component of the study, as some studies consisted of multiple components. Articles were
categorised according to the included articles’ descriptions of their interventions and the researchers’
own judgments. Interventions were classified into categories that included pharmacists’ perspectives
regarding medication use in adolescent patients, perspectives of adolescents and parents regarding
their knowledge and medication use experiences and examples of pharmaceutical care programmes
that are provided to young people.
3.2.1. Pharmacists’ Perspectives Regarding Medication Use in Adolescent Patients
Exploring pharmacists’ perspectives regarding medication use in adolescents was the key objective
in three studies [14,16,18]. In the first study [14], there was a structured interview questionnaire that
contained questions on medication-related problems in adolescents (especially adherence), the rate
of community pharmacist meetings with adolescents (counselling, filling prescriptions) and finally
a question about possibilities to improve medication use in young people. The second study [16]
included three phases: Focus groups with community and hospital pharmacists, telephone interviews
with pharmacy and rheumatology stakeholders and commissioners and multidisciplinary group
discussions to prioritize roles generated by the first two qualitative phases. In the first phase, the
opinions and experiences of a various group of practicing community and hospital pharmacists about
their engagement with adolescents with chronic illness were elicited. This was followed by a second
phase to share pharmacists’ ideas about their current and future roles in the support of adolescents
with chronic illness, with stakeholders producing a list of roles for prioritisation. The final phase was
to encourage pharmacists and rheumatology specialists to prioritise roles to be enhanced or developed.
In the third study [18], community pharmacists were asked about their experiences over the last year
with young people with chronic illnesses. Many issues were included in the questionnaire, such
as administration and obtaining medication, information requests, reported adherence, medication
review and adverse effects.
3.2.2. Observation of Community Pharmacists’ Interactions with Young People and Their Carers
In this study [20], the researchers followed an observation guide to record information about
prescriptions that were collected for young people. Eight points were documented by research
assistants, which included the time of prescription collection, the person who collected the prescription,
the person who was counselled by the pharmacist, which pharmacy staff members interacted with the
family, the location of pick-up, wait time, how many questions the adolescent or carers asked pharmacy
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staff and the carers gender. The demographic data of the adolescent and medication information were
obtained from the prescription.
3.2.3. Perspective of Adolescents and Parents Regarding Their Knowledge and Medication
Use Experiences
One study [15] explored the perspective of adolescents and parents regarding their knowledge
and medication use experiences. The intervention used semi-structured interviews to understand
the perspectives of adolescents and parents regarding adolescent knowledge and medication
use experiences, facilitators of patient counselling and perceptions of community pharmacists.
Twenty-minute interviews were conducted by a pharmacy researcher and a research assistant.
Interviews were face-to-face for local participants and via telephone for distant participants. The same
interview guides were used at both study sites. A participant’s gender, age, race and ethnicity, parent
marital status, education and grade level and annual household income were collected.
3.2.4. Pharmaceutical Care Programmes Provided to Young People
Pharmacists provided healthcare services to young people in two studies [17,19]. In the first
study [19], young people with moderate asthma who were scheduled for outpatient visits with their
internist over a 12-month period were referred for a pharmacist intervention. Participants attending the
clinic were allocated into two groups, the intervention group (A) or control group (B). Participants in
group A were educated on their disease, self-management, inhalation techniques and pharmacotherapy.
Patients in control group (B) were without a pharmaceutical intervention and on their regular treatment
for asthma. Spirometry was performed at the beginning of the study and at the completion of nine
weeks for both groups. All patients used beta-agonists. To assess the quality of life, a paediatric
asthma quality-of-life questionnaire (PAQLQ) was applied to the intervention and control groups at
the beginning, after two weeks and after nine weeks. The intervention in the second study [17] aimed
to identify metabolic syndrome in high-risk adolescents. At the beginning of the study, a medical
history was obtained, a physical examination was performed and a fasting laboratory analysis was
carried out. To determine if the adolescent met the criteria for diagnosis, the clinical pharmacist
evaluated each component of metabolic syndrome. Then, a summary of the risk factors and treatment
recommendations was provided to the paediatrician by the clinical pharmacist.
3.2.5. Intervention to Improve the Use of Medicines in Young People
A literature review [3] identified interventions on managing medicines in children. The aim was
to provide underpinning evidence on the development of advice for managing medicines. This article
focused on four areas: Medication review, concordance, enhanced medicine access through community
pharmacy services and the use of medicines in schools. Following the eligibility criteria of our review,
this report concentrates on “medication review” and “concordance”.
3.3. Assessment of Outcomes
3.3.1. Pharmacists’ Perspectives Regarding Medication Use in Adolescent Patients
This review aimed to explore the role of the primary care pharmacist in the management of
chronic illnesses in young people. The high-priority roles for pharmacists that were identified by
community pharmacists included developing generic healthcare skills among adolescents, building
trusting relationships and direct contact with young people instead of parents, counselling with a
concentration on the necessity/benefits of taking medicine, helping adolescents to find credible online
health information and use digital media for educational purposes or reminder services, transferring
information effectively across care interfaces and developing specialist expertise [14,16]. Around
one-half of community pharmacists experienced problems related to medicines and young people.
Prescription collection by the parents with or without the adolescent was recognised as an important
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reason for medication-related problems in adolescents [14]. Pharmacists reported that up to 42.9%
of adolescents and/or their carers present to them with nonadherence issues, including stopping
medication [14,18].
3.3.2. Perspectives of Adolescents and Parents Regarding Their Knowledge and Medication
Use Experiences
Young people and their parents/carers consider community pharmacists to be a resource for
information regarding long-term prescribed medication [18]. One study [15] qualitatively explored the
perspective of adolescents and parents regarding their knowledge and medication use experiences.
Adolescents had minimal knowledge about their medicines, although they were independently
managing their medications. The adolescent’s absence during medication collection at pharmacies was
a barrier to receiving counselling by pharmacists, as reported by adolescents and parents. Adolescents
showed acceptance and were receptive to pharmacists providing education about their medications.
The use of educational and interactive technologies for young people consultations were recommended
by parents and children.
3.3.3. Pharmaceutical Care Programmes Provided to Young People
Two studies [17,19] evaluated the role of the community pharmacist in providing healthcare
services to young people with chronic illnesses (metabolic disease and asthma). Both studies showed
significant results in terms of improvement in adolescents’ quality of life and improvement in their
knowledge about their disease and its treatment. In the first study [17], a clinical pharmacist provided
treatment recommendations for over two-thirds of the young people who participated in the study.
The authors concluded that clinical pharmacists can have an effective role in the early identification of
specific components of metabolic syndrome. In the other study [19], there was a statistically significant
improvement in all of the study’s domains (activities, emotions and symptoms) in the young people
who received pharmaceutical care in comparison to those who did not receive it. An improvement
in the quality of life of the young people who received pharmacist interventions was reported by
the authors.
4. Discussion
4.1. The Findings
This review was carried out to explore the role of the pharmacist in the management of chronic
illnesses in young people in a primary care setting. Eight studies were identified: Interpretation was
complex due to the heterogeneity of the studies. The studies were heterogeneous because of the
different designs and difference in populations and goals of interventions, and the literature in this area
was scarce. The high-priority roles for pharmacists that were identified by community pharmacists
included developing generic healthcare skills among adolescents, such as prescription refills and
getting free prescriptions; building trusted relationships and direct contact with young people instead
of parents; counselling with a concentration on the necessity/benefits of taking medicine; helping
adolescents to find credible online health information and use digital media for educational purposes or
reminder services; transferring information effectively across care interfaces; and developing specialist
expertise [14,16].
It is anticipated that these roles could inform future steps in enhancing the function of community
pharmacists in supporting adolescents with chronic diseases [19]. Adolescents are more likely than
adults to consider pharmacists as a trustworthy source of information. A survey with a sample size of
4182 was conducted across Germany, Portugal, France and the United Kingdom in 2014 and reported
that young people may be more open than adults to utilising a pharmacist as a health information
reference [21]. Therefore, resources for providing appropriate care to adolescents, including cognitive
and physical development information, should be included in pharmacist training programmes at
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undergraduate and postgraduate levels. In addition, pharmacists must develop enough specialist
knowledge to make certain that medication use is safe for all young people [16]. This can be achieved
through the provision of continuous professional development courses and by encouraging pharmacists
to attend such training opportunities provided by pharmacy educational and training bodies.
Pharmacists can play a vital role in identifying patients with medication-related problems.
However, there is limited direct contact between community pharmacists and young people. Mostly,
parents fill prescriptions at the pharmacy, which might be a cause of medication-related problems among
young people being missed [14]. The nonattendance of adolescents during prescription collection may
decrease opportunities for communication between pharmacists and adolescents [15]. This has also
been reported in other studies: For example, Slack et al., 1995 [22], showed that pharmacists have only
a little contact with adolescents. This forms a potential barrier between pharmacists and the adolescent
that prevents medication counselling and the provision of instructions related to specific medications,
such as the use of subcutaneous injections or inhalers.
In our review, adolescents were accompanied by their parents during prescription collection
almost 32% of the time [15,20]. This finding is similar to that found in previous studies (32% and
50%) [23,24]. Providing counselling by pharmacists to adolescents was very rare even when they were
present at the pharmacy [15,20]. Only 2% of adolescents were counselled by their pharmacist [20]. A
number of factors may contribute to a low adolescent counselling rate, which have been mentioned in
other studies, including a lack of parent interest, a high daily prescription volume, a lack of pharmacist
confidence in communicating effectively with adolescents and a lack of time [23–25].
It was found that young people aged 10 to 17 years were managing their medicines independently
even though they had only a small amount of information about their medications [15]. In contrast,
other studies have found that young people with chronic illnesses have expressed worry and fear
about self-managing their illnesses [26,27]. Evidence from previous studies has revealed that effective
communication with healthcare providers such as pharmacists is deemed to be an approach to
improving adolescents’ knowledge and self-management of medications [24,28]. Pharmacists can
instruct young people with chronic illnesses on strategies to aid in long-term adherence. This includes
ensuring appropriate medication use and showing the proper use of medical devices, for example,
metered-dose inhalers [29,30].
Furthermore, the use of social media could be useful in reaching adolescent patients. This tool
might enhance adolescents’ medication use behaviour [31]. Young people prefer technology-based
education [32,33], and video-based education can improve adolescents’ medication experience [20,29,34].
To encourage patient engagement in disease management, a dashboard with health information was
proposed by Judson et al., 2013 [35]. Furthermore, in this review, Koster et al., 2015, [14] suggested the
use of new media, text messages, applications and smartphones as solutions to promote counselling
and connection with young people.
Community pharmacists have encountered many adolescent-related medication experiences
presented to them in their pharmacies. These have included information needs, adherence, formulation
issues, medication refills and adverse effects [18]. In a review by Staples and Bravender, 2002 [36],
which reviewed studies focusing on medication adherence in adolescents, nonadherence reached a
peak during adolescence. The range of adherence found was from 10% to 96%. Nonadherence to
medication could be seen in patients as a consequence of the information gap that formed when they
commenced their new medication [18]. A previous study in adult patients prescribed a new chronic
medication showed that once a patient has taken his/her medication, he/she obtains knowledge about
the effect of the drug, and at the same time, new inquiries about the medication arise [37]. In this review,
Aston et al., 2017 [18], found that young people ceased taking medication or changed the dose without
any advice from the prescriber. This decision was taken either by themselves or through a parent/carer.
In Aston et al., 2017 [18], intentional nonadherence was reported by participants more frequently
than unintentional nonadherence. More research is needed to explore intended nonadherence in this
patient population.
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A study by Koster et al., 2015 [14], reported that low perceived necessity and forgetting to take
medication were important reasons for young people not to use medication as prescribed. This result
is supported by previous studies [38–40]. Solutions that were suggested by community pharmacists to
overcome these reasons included specific counselling in the community pharmacy to improve patients’
knowledge and a special focus on the benefits and necessity of medicines [14].
The indication, administration, dose and adverse effects of a medication were the most requested
information by patients or their parents/carers [18]. A review by Ryan et al., 2014 [41], which reviewed
studies focusing on interventions to improve the safe and effective use of medication by consumers,
indicated a scarcity of evidence in adolescents regarding such information. Medication use review
services for young people should be extended to provide enhanced contact between young people and
community pharmacists to discuss medication issues [18].
4.2. Strengths and Limitations
This systematic review had several limitations, which included the short time frame and the
heterogeneity of the studies in their methodology and outcomes. In addition, a relatively small number
of studies were included, and the systematic review was limited to English language publications
only. This study was limited by a focus on chronic conditions and did not consider the array of
public health/acute health problems in which pharmacists may be able to support young people. The
strengths of the review were that this systematic review applied a vigorous systematic search using
diverse databases to identify relevant studies, and it had a focus on pharmacist interventions only.
4.3. Implications for Practice
The findings from this review are important for healthcare policymakers and healthcare providers.
The provision and evaluation of necessary education and training for community pharmacists is
paramount. Training on digital technologies and social media is an area that needs to be focused
on to reach young people, and it has the potential to enhance their medication use behaviour. An
enhancement of current medicine use review services for young people and their parents would
provide an opportunity for community pharmacists to optimise medication use. The education of
adolescents with chronic illnesses on strategies to support medication adherence is very important, as
the evidence suggests that medication adherence is generally low in adolescents. As there is such a
small amount of published work in this area, this highlights the need for additional research to be
carried out and published.
5. Conclusions
There is a lack of published literature regarding the role of primary care pharmacists in the
management of chronic illness in young people. Where pharmacists have managed chronic illnesses in
this population, they have been community-based and have had a positive impact on patient outcomes.
Pharmacists feel that they have a role to play in supporting young people with chronic illness and
have identified many areas where they can provide services and support. However, many pharmacists
perceive a fundamental communication barrier that hinders the provision of this support, i.e., lack of
access to the patient. Further research is necessary to provide more evidence of the benefit of primary
care pharmacists in supporting young people with their medications.
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Appendix A
Table A1. Characteristics of the publications included in the review.
Study Study Aims Study Type Setting Participants
Gray et al. [16], 2017
To explore the perceived and
potential roles of pharmacists in
the care of young people aged
10–24 years with chronic illness,
through the exemplar of
juvenile arthritis.
Sequential mixed methods:
The first two phases–pharmacist
focus groups and stakeholder
telephone interviews—were
qualitative. The final
phase—multidisciplinary
discussion groups—was a
quantitative approach
Phase 1:
Pharmacist focus groups were
facilitated by the project
manager.
Phase 3:
Multidisciplinary discussion
groups were convened at
targeted paediatric
rheumatology centres across
England and
Scotland.
4 focus groups:
9 community pharmacists,
9 hospital Pharmacists.
15 telephone interviews:
2 pharmacy policymakers,
3 service commissioners,
2 pharmacy staff members,
5 rheumatology professionals,
3 lay advocates.
3 Discussion groups:
9 community pharmacists,
4 hospital pharmacists,
7 rheumatology physicians,
5 specialist nurses,
1 physiotherapist.
Abraham et al. [15], 2017
To explore the perspectives of
children and parents regarding
paediatric patients’ knowledge
and medication use experiences
with chronic illnesses, how they
want to learn about medicines
and perceptions of community
pharmacist-provided
counselling.
Qualitative study using
semi-structured interviews and
thematic analyses.
Three community pharmacies
in two eastern states: One in
western North Carolina and two
in the region of western
Pennsylvania.
39 participants:
20 children using medications
for chronic illnesses,
19 parents.
Carpenter et al. [20], 2016
To characterize community
pharmacists’ interactions with
children and their caregivers.
14-day observational study.
Three community pharmacies,
one located in a western North
Carolina town and two located
in western Pennsylvania.
97 families
Pharmacy 2019, 7, 89 11 of 13
Table A1. Cont.
Study Study Aims Study Type Setting Participants
Benavides et al. [17], 2011
To evaluate the role of a clinical
pharmacist in screening
children and adolescents for
metabolic syndrome.
Three-month, prospective,
cross-sectional study.
Paediatric ambulatory clinic
located in a community health
centre in Texas.
25 participants
González-Martin et al. [19],
2003
To evaluate the impact of a
pharmaceutical care program on
children with asthma.
Paediatric asthma quality-of-life
questionnaire (PAQLQ)in two
groups of children:A and B.
Outpatient paediatric clinic of
the Catholic University of Chile.
21 recruited children:
Group A (11 children),
Group B (10 children).
Koster et al. [14], 2015
To explore pharmacy staff’s
perspectives regarding
medication use behaviour in
adolescent patients.
Structured face-to-face
interviews.
Community pharmacies in
Utrecht.
170 members:
53 pharmacists,
109 technicians,
8 other functions.
Aston et al. [18], 2017
To determine whether
community pharmacists
undertake medication reviews
with children/young people or
their parents/carers and to
identify the type of
medication-related experiences
that are presented to
community pharmacists when a
child/young person is taking
long-term prescribed
medication.
Semi-structured
questionnaire.
England-based
community pharmacists. 76 pharmacists
Costello et al. [3], 2004
To provide underpinning
evidence in the development of
advice on managing medicines
for children and young people.
Literature review. - 31 studies
Pharmacy 2019, 7, 89 12 of 13
References
1. Office of National Statistics. General Household Survey; HMSO: London, UK, 2006.
2. Prescriptions Dispensed in the Community. Statistics for England 2007–2017 NHS Digital. 2015. Available
online: https://digital.nhs.uk/data-and-information/publications/statistical/prescriptions-dispensed-in-the-
community/prescriptions-dispensed-in-the-community-england---2007---2017 (accessed on 11 April 2019).
3. Costello, I.; Wong, I.C.K.; Nunn, A.J.A. literature review to identify interventions to improve the use of
medicines in children. Child Care Health Dev. 2004, 30, 647–665. [CrossRef] [PubMed]
4. Gardner, P.; Dvorkin, L. Promoting Medication Adherence in Children. Am. Fam. Physician 2006, 74, 793–798.
Available online: www.aafp.org/afp (accessed on 11 May 2019).
5. Dundee, F.D.; Dundee, D.M.; Noday, D.M. Pediatric Counseling and Medication Management Services:
Opportunities for Community Pharmacists. J. Am. Pharm. Assoc. 2002, 42, 556–567. [CrossRef]
6. Campbell, F.; Biggs, K.; Aldiss, S.; O’Neill, P.; Clowes, M.; McDonagh, J.; While, A.; Gibson, F. Transition of
care for adolescents from paediatric services to adult health services. Cochrane Database Syst. Rev. 2016, 4,
CD009794. [CrossRef] [PubMed]
7. Langford, N. Therapeutic misadventure. Med. Sci. Law 2010, 50, 179–182. [CrossRef] [PubMed]
8. Department of Health. National Service Framework for Children, Young People and Maternity Services; Medicines
for Children and Young People Report; Department of Health and Social Care: London, UK, 2004.
9. International Comparisons of Health and Wellbeing in Adolescence and Early Adulthood. Available
online: https://www.nuffieldtrust.org.uk/research/international-comparisons-of-health-and-wellbeing-in-
adolescence-and-early-adulthood (accessed on 3 July 2019).
10. Farmer, J.; Marien, W.; Clark, M.; Sherman, A.; Selva, T. Primary Care Supports for Children with Chronic
Health Conditions: Identifying and Predicting Unmet Family Needs. J. Pediatri. Psychol. 2004, 29, 355–367.
[CrossRef] [PubMed]
11. Critical Appraisal Skills Programme 2018. CASP (Qualitative) Checklist. Available online: https://casp-uk.
net/wp-content/uploads/2018/01/CASP-Qualitative-Checklist-2018.pdf (accessed on 19 February 2019).
12. Critical Appraisal Skills Programme 2018. CASP (Cohort Study) Checklist. Available online: https:
//casp-uk.net/wp-content/uploads/2018/03/CASP-Cohort-Study-Checklist-2018_fillable_form.pdf (accessed
on 19 February 2019).
13. Critical Appraisal Skills Programme 2018. CASP (Systematic Review) Checklist. Available online: https://casp-
uk.net/wp-content/uploads/2018/03/CASP-Systematic-Review-Checklist-2018_fillable-form.pdf (accessed
on 19 February 2019).
14. Koster, E.S.; Philbert, D.; Winters, N.A.; Bouvy, M.L. Medication adherence in adolescents in current practice:
Community pharmacy staff’s opinions. Int. J. Pharm. Pract. 2015, 23, 221–224. [CrossRef] [PubMed]
15. Abraham, O.; Brothers, A.; Alexander, D.S.; Carpenter, D.M. Pediatric medication use experiences and
patient counseling in community pharmacies: Perspectives of children and parents. J. Am. Pharm. Assoc.
2017, 57, 38–46. [CrossRef]
16. Gray, N.J.; Shaw, K.L.; Smith, F.J.; Burton, J.; Prescott, J.; Roberts, R.; Terry, D.; McDonagh, J.E. The Role of
Pharmacists in Caring for Young People With Chronic Illness. J. Adolesc. Health 2017, 60, 219–225. [CrossRef]
17. Benavides, S.; Kohler, L.A.; Souffrant, G. A Clinical Pharmacist’s Role in Screening for Metabolic Syndrome
in a Rural Pediatric Ambulatory Clinic. J. Rural Health 2011, 27, 184–189. [CrossRef]
18. Aston, J.; Wilson, K.A.; Terry, D.R.P. Children/young people taking long-term medication: A survey of
community pharmacists’ experiences in England. Int. J. Pharm. Pract. 2017, 26, 104–110. [CrossRef]
[PubMed]
19. González-Martin, G.; Joo, I.; Sánchez, I. Evaluation of the impact of a pharmaceutical care program in
children with asthma. Patient Educ. Couns. 2003, 49, 13–18. [CrossRef]
20. Carpenter, D.M.; Abraham, O.; Alexander, D.S.; Horowitz, K. Counseling of children and adolescents in
community pharmacies: Results from a 14-day observational study. J. Am. Pharm. Assoc. 2016, 56, 266–269.
[CrossRef] [PubMed]
21. International Longevity Centre. Available online: http://www.ilcuk.org.uk (accessed on 18 February 2019).
22. Slack, M.; Brooks, A. Medication management issues for adolescents with asthma. Am. J. Health Syst. Pharm.
1995, 52, 1417–1421. [CrossRef] [PubMed]
Pharmacy 2019, 7, 89 13 of 13
23. Pradel, F.; Obeidat, N.; Tsoukleris, M. Factors affecting pharmacists’ pediatric asthma counseling. J. Am.
Pharm. Assoc. 2007, 47, 737–754. [CrossRef] [PubMed]
24. Nilaward, W.; Mason, H.; Newton, G. Community Pharmacist–Child Medication Communication: Magnitude,
Influences, and Content. J. Am. Pharm. Assoc. 2005, 45, 354–362. [CrossRef]
25. Ranelli, P.; Bartsch, K.; London, K. Pharmacists’ perceptions of children and families as medicine consumers.
Psychol. Health 2000, 15, 829–840. [CrossRef]
26. Tuchman, L.; Slap, G.; Britto, M. Transition to adult care: Experiences and expectations of adolescents with a
chronic illness. Child Care Health Dev. 2008, 34, 557–563. [CrossRef]
27. Porter, J.; Graff, J.; Lopez, A.; Hankins, J. Transition From Pediatric to Adult Care in Sickle Cell Disease:
Perspectives on the Family Role. J. Pediatr. Nurs. 2014, 29, 158–167. [CrossRef]
28. Conard, L.; Fortenberry, J.; Blythe, M.; Orr, D. Pharmacists’ Attitudes Toward and Practices With Adolescents.
Arch. Pediatr. Adolesc. Med. 2003, 157, 361–365. [CrossRef]
29. Bynum, A.; Hopkins, D.; Thomas, A.; Copeland, N.; Irwin, C. The Effect of Telepharmacy Counseling on
Metered-Dose Inhaler Technique among Adolescents with Asthma in Rural Arkansas. Telemed. J. e-Health
2001, 7, 207–217. [CrossRef] [PubMed]
30. Wu, Y.; Pai, A. Health Care Provider-Delivered Adherence Promotion Interventions: A Meta-Analysis.
Pediatrics 2014, 133, e1698–e1707. [CrossRef] [PubMed]
31. Hyden, C.; Cohall, A. Innovative approaches to using new media and technology in health promotion for
adolescents and young adults. Adolesc. Med. State. Art Rev. 2011, 22, 498–520. [PubMed]
32. Ayala, G.; Miller, D.; Zagami, E.; Riddle, C.; Willis, S.; King, D. Asthma in Middle Schools: What Students
Have to Say About Their Asthma. J. Sch. Health 2006, 76, 208–214. [CrossRef] [PubMed]
33. Baptist, A.; Thompson, M.; Grossman, K.; Mohammed, L.; Sy, A.; Sanders, G. Social Media, Text Messaging,
and Email—Preferences of Asthma Patients between 12 and 40 Years Old. J. Asthma 2011, 48, 824–830.
[CrossRef] [PubMed]
34. Carpenter, D.; Lee, C.; Blalock, S.; Weaver, M.; Reuland, D.; Coyne-Beasley, T.; Mooneyham, R.; Loughlin, C.;
Geryk, L.; Sleath, B. Using videos to teach children inhaler technique: A pilot randomized controlled trial.
J. Asthma 2014, 52, 81–87. [CrossRef] [PubMed]
35. Judson, T.; Detsky, A.; Press, M. Encouraging Patients to Ask Questions. White Coat Silenc. 2013, 309,
2325–2326. [CrossRef] [PubMed]
36. Staples, B.; Bravender, T. Drug Compliance in Adolescents. Pediatr. Drugs 2002, 4, 503–513. [CrossRef]
[PubMed]
37. Barber, N.; Parsons, J.; Clifford, S.; Darracott, R.; Horne, R. Patients’ problems with new medication for
chronic conditions. Qual. Saf. Health Care 2004, 13, 172–175. [CrossRef]
38. Wamboldt, F.; Bender, B.; Rankin, A. Adolescent Decision-Making about Use of Inhaled Asthma Controller
Medication: Results from Focus Groups with Participants from a Prior Longitudinal Study. J. Asthma 2011,
48, 741–750. [CrossRef]
39. Buchanan, A.; Montepiedra, G.; Sirois, P.; Kammerer, B.; Garvie, P.; Storm, D.; Nichols, S. Barriers to
Medication Adherence in HIV-Infected Children and Youth Based on Self- and Caregiver Report. Pediatrics
2012, 129, e1244–e1251. [CrossRef] [PubMed]
40. Axelsson, M. Personality and reasons for not using asthma medication in young adults. Heart Lung 2013, 42,
241–246. [CrossRef] [PubMed]
41. Ryan, R.; Santesso, N.; Lowe, D.; Hill, S.; Grimshaw, J.; Prictor, M.; Kaufman, C.; Cowie, G.; Taylor, M.
Interventions to improve safe and effective medicines use by consumers: An overview of systematic reviews.
Cochrane Database Syst. Rev. 2014, 29, CD007768. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
